CXCL13 and non-Hodgkin lymphoma: Serum concentrations of CXCL13 were significantly elevated in all pSS groups compared to healthy controls (p < 0.0001) (see Fig. 1) and in pSS-NHL+ patients compared to pSS-nonL patients (p = 0.0204) (see Supplementary Fig. S2).